CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Open-market buy CEO & President bought 5,000 shares at $0.30 ($1,515)
- 4 Open-market buy CEO & President bought 20,000 shares at $0.31 ($6,160)
- 4 Grant or award CEO & President acquired 312,500 shares (grant or award)
- 4 Grant or award COO, Secretary, Gen. Counsel acquired 188,679 shares (grant or award)
- 4 Grant or award CEO & President acquired 377,358 shares (grant or award)
- 4 Open-market buy CEO & President bought 61,729 shares at $0.41 ($25,000)
- 4 Open-market buy COO, Secretary, Gen. Counsel bought 30,865 shares at $0.41 ($12,500)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 38,462 shares at $0.39 ($15,000)
- 4 Open-market buy Director bought 90,910 shares at $0.33 ($30,000)
- 4 Open-market buy COO, Secretary, Gen. Counsel bought 37,879 shares at $0.33 ($12,500)
- 4 Open-market buy CEO & President bought 75,758 shares at $0.33 ($25,000)
- 4 Open-market buy CEO & President bought 33,861 shares at $0.44 ($15,000)
- 4 Open-market buy CEO & President bought 22,676 shares at $0.44 ($10,000)
- 4 Open-market buy CEO & President bought 8,222 shares at $0.67 ($5,501)
- 4 Open-market buy CEO & President bought 14,993 shares at $0.67 ($10,000)
- 4 Open-market buy CEO & President bought 16,950 shares at $0.59 ($10,001)
- 3 Insider Initial Statement of Ownership
- 4 Other disposition Director disposed of 68,208 shares (other)
Page 4 of 31 · 614 filings